Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Russell

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Synthesis of cinnamic acids and related isosteres as potent and selective alpha v beta 3 receptor antagonistsThomas D Penning, Mark A Russell, Barbara B Chen, et al.
Islets|December 9, 2010
Pseudoislets as primary islet replacements for research: report on a symposium at King's College London, London UKShanta J Persaud, Catherine Arden, Peter Bergsten, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolaseThomas D Penning, Nizal S Chandrakumar, Bipin N Desai, et al.
Nature Genetics|July 21, 2014
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune diseaseSarah E Flanagan, Emma Haapaniemi, Mark A Russell, et al.
Diabetes|March 6, 2019
HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 DiabetesMark A Russell, Sambra D Redick, David M Blodgett, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolaseThomas D Penning, Nizal S Chandrakumar, Bipin N Desai, et al.
Journal of Medicinal Chemistry|July 26, 2002
Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acidThomas D Penning, Mark A Russell, Barbara B Chen, et al.
Brain : a Journal of Neurology|November 1, 2017
Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localizationHaicui Wang, Claire G Salter, Osama Refai, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Synthesis of pyrazoles and isoxazoles as potent alpha(v)beta3 receptor antagonistsThomas D Penning, Albert Khilevich, Barbara B Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2005
Synthesis of 2,5-thiazole butanoic acids as potent and selective alpha(v)beta3 integrin receptor antagonists with improved oral pharmacokinetic propertiesJohn A Wendt, Hongwei Wu, Heather G Stenmark, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Synthesis of cinnamic acids and related isosteres as potent and selective alpha v beta 3 receptor antagonistsThomas D Penning, Mark A Russell, Barbara B Chen, et al.
Islets|December 9, 2010
Pseudoislets as primary islet replacements for research: report on a symposium at King's College London, London UKShanta J Persaud, Catherine Arden, Peter Bergsten, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolaseThomas D Penning, Nizal S Chandrakumar, Bipin N Desai, et al.
Nature Genetics|July 21, 2014
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune diseaseSarah E Flanagan, Emma Haapaniemi, Mark A Russell, et al.
Diabetes|March 6, 2019
HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 DiabetesMark A Russell, Sambra D Redick, David M Blodgett, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolaseThomas D Penning, Nizal S Chandrakumar, Bipin N Desai, et al.
Journal of Medicinal Chemistry|July 26, 2002
Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acidThomas D Penning, Mark A Russell, Barbara B Chen, et al.
Brain : a Journal of Neurology|November 1, 2017
Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localizationHaicui Wang, Claire G Salter, Osama Refai, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Synthesis of pyrazoles and isoxazoles as potent alpha(v)beta3 receptor antagonistsThomas D Penning, Albert Khilevich, Barbara B Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2005
Synthesis of 2,5-thiazole butanoic acids as potent and selective alpha(v)beta3 integrin receptor antagonists with improved oral pharmacokinetic propertiesJohn A Wendt, Hongwei Wu, Heather G Stenmark, et al.
Pageof 8